Biolevate Secures €30 Million Series A Funding and Expands to Boston
Biolevate, a company specializing in life sciences AI, has announced it raised €30 million in Series A funding. The investment round was led by RAISE France and Orange Ventures, and the company also confirmed the opening of a new office in Boston. This information, indicating a significant expansion of its operations, was reported across Tech.eu, The Next Web, and Pulse 2.0, likely originating from a company press release.
3 articles from 3 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
3 outlets covered “Biolevate Secures €30 Million Series A Funding and Expands to Boston”. All of them report the following:
- Biolevate secured Series A funding
- Funding amount is €30 million
- Company focuses on life sciences AI
- Company expanded operations to Boston
- RAISE France and Orange Ventures led the funding round
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.